SPONSOR

University of California, Los Angeles

Total Trials

Recruiting

Phases

Phase 2, EARLY_Phase 1, Phase 4, Phase 3

Conditions studied: Alcohol Use Disorder Post-operative Pain Management Sleep Apnea, Obstructive Memory Cognitive Function Mid-membranous Vocal Fold Lesion Type2diabetes Postpartum Hypertension (PPHT)NON APPLICABLE Spinal Cord Injury

University of California, Los Angeles is a clinical research sponsor with 24 registered studies on ClinicalTrials.gov, of which 24 are actively recruiting participants. Research covers conditions including Alcohol Use Disorder, Post-operative Pain Management, Sleep Apnea, Obstructive, Memory.

The trial portfolio spans Phase 2, EARLY_Phase 1, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of California, Los Angeles

How many clinical trials has University of California, Los Angeles sponsored?

ClinicalMetric currently tracks 24 clinical trials sponsored by University of California, Los Angeles, of which 24 are actively recruiting participants. These trials cover conditions including Alcohol Use Disorder, Post-operative Pain Management, Sleep Apnea, Obstructive. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does University of California, Los Angeles research focus on?

University of California, Los Angeles clinical trials span Alcohol Use Disorder, Post-operative Pain Management, Sleep Apnea, Obstructive, Memory, Cognitive Function, and additional conditions. The research pipeline includes Phase 2, EARLY_Phase 1, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a University of California, Los Angeles clinical trial?

To participate in a University of California, Los Angeles trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of California, Los Angeles trials with current recruitment status updated daily.

University of California, Los Angeles

Frequently Asked Questions — University of California, Los Angeles

Clinical Trials by University of California, Los Angeles

Motivation for IV Alcohol Self-Administration in Humans

Intercostal Cryoanalgesia in Double Lung Transplant Recipients

Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea

Effect of Daily Mixed Spice Consumption on Memory Function

Laryngeal and Vocal Tract Strategies to Reduce Vocal Fold Contact Pressure

Type 2 Diabetes and Blood Brain Barrier Improvement

PEACE Trial: Postpartum Evaluation of Antihypertensive Cessation and Efficacy

Diet Quality Pilot Intervention in LA Safety Net

Improving Bladder Function in SCI by Neuromodulation

A Study to Prevent Infantile Spasms Relapse

Transvaginal Electrical Stimulation for Myofascial Pelvic Pain

Ongoing Dynamic Choice to Address HIV Treatment Interruption in Malawi

Polyphenols and Cognitive Decline

Brain Imaging Biomarkers for Response to Spinal Cord Stimulation in Patients With Chronic Low Back Pain

Thiamine Intervention and Coronary Artery Bypass Grafting

An Integrated Intervention Using a Pill Ingestible Sensor System

Hemorrhoidal Artery Embolization: Longitudinal Impact On Symptoms (HELIOS)

Beacon Sensors and Telerehabilitation to Assess and Improve Use of Devices (BeST-AID) for Low Vision

Optimizing Treatment of Adhesive Small Bowel Obstruction

Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure

Mentor Moms+ Study

DETERMINE: Detemir vs NPH

Effects of Acupuncture on Symptoms of Stable Angina

Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis